EGFR has been relatively well-studied in AD, with a review suggesting that EGFR inhibition is critical for modulating the amyloid pathway as it contributes to microtubule stabilization and attenuates the secretion of pro-inflammatory molecules to reduce severe neuronal degeneration (Jayaswamy et al., 2023). This evidence concerns the gene EGFR and Alzheimer disease.